Vitiligo induced by dupilumab treatment: A case series.

New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases. Four patients (57.1%) noted new onset vitiligo, while three (42.8%) had a past history of stable vitiligo despite no treatment (i.e. no reported new or enlarging lesions) and presented with worsening vitiligo after dupilumab (Figure 1). [Extracted from the article]